NCT00005356View on ClinicalTrials.gov

Novel Hemostatic Cardiac Risk Factors in Framingham

CompletedOBSERVATIONAL
Timeline

Start Date

July 31, 1994

Study Completion Date

May 31, 1998

Conditions
Cardiovascular DiseasesHeart DiseasesDeath, Sudden, CardiacMyocardial InfarctionThrombosisAtherosclerosisCarotid Artery Diseases
All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00005356 - Novel Hemostatic Cardiac Risk Factors in Framingham | Biotech Hunter | Biotech Hunter